Global fibrinolytic capacity in pediatric patients with sepsis and disseminated intravascular coagulation

Blood Coagulation and Fibrinolysis

Volumn 17, Issue 7, 2006, Pages 569-573

  Bay, Ali ^a   Oner, Ahmet Faik ^a   Kose, Dogan ^a   Dogan, Murat ^a  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

Author keywords

Coagulation; Global fibrinolytic capacity; Sepsis

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTITHROMBIN; ASPARTATE AMINOTRANSFERASE; BLOOD CLOTTING FACTOR; D DIMER; FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; PROTEIN S; PROTHROMBIN; THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; APACHE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTERIAL MENINGITIS; BACTERIAL PERITONITIS; BACTERIAL PNEUMONIA; BLOOD CLOT LYSIS; BLOOD CLOTTING TEST; BLOOD CULTURE; CHILD; CHILDHOOD MORTALITY; CONTROLLED STUDY; DISSEMINATED INTRAVASCULAR CLOTTING; ESCHERICHIA COLI; EUGLOBULIN LYSIS TEST; FEMALE; FIBRINOLYSIS; GASTROENTERITIS; HUMAN; HUMAN TISSUE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEWBORN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTHROMBIN TIME; SEPSIS; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE; THROMBOCYTE;

BLOOD COAGULATION TESTS; CHILD; CHILD, PRESCHOOL; DISSEMINATED INTRAVASCULAR COAGULATION; FEMALE; FIBRINOLYSIS; HUMANS; INFANT; MALE; SEPSIS;

EID: 33748929320     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mbc.0000245304.95138.cf     Document Type: Article

References (25)

1. Gogos CA, Lekkou A, Papageorgiou O, Siagris D, Skoutelis A, Bassaris HP. Clinical prognostic markers in patients with severe sepsis: a prospective analysis of 139 consecutive cases. J Infect 2003; 47:300-306.
2. van Deventer SJ, Buller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 1990; 76:2520-2526.
3. Zeerleder S, Schroeder V, Hack CE, Kohler HP, Wuillemin WA. TAFI and PAI-1 levels in human sepsis. Thromb Res 2006; 118:205-212.
4. Bajzar L, Manuel R, Nesheim ME. Purification and characterization of TAFI, a thrombinactivable fibrinolysis inhibitor. J Biol Chem 1995; 270:14477-14484.
5. Cicala C, Cirino G. Linkage between inflammation and coagulation: an update on the molecular basis of the crosstalk. Life Sci 1998; 62:1817-1824.
6. Asakura H, Sano Y, Yamazaki M, Morishita E, Miyamoto K, Nakao S. Role of fibrinolysis in tissue-factor-induced disseminated intravascular coagulation in rats - an effect of tranexamic acid. Haematologica 2004; 89:757-758.
7. Gando S, Kameue T, Matsuda N, Hayakawa M, Hoshino H, Kato H. Serial changes in neutrophil-endothelial activation markers during the course of sepsis associated with disseminated intravascular coagulation. Thromb Res 2005; 116:91-100.
8. Amiral J, Malmejac A, Gin H, Pannell R, Vissac AM, Seigneur M, et al. Evaluation of the fibrinolytic potential on plasma: physiological and pathological variations and association with cardiovascular disease risk factors. Fibrin Proteol 1999; 13:1-10.
9. Members of the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-874.
10. Taylor FB Jr, Toh CH, Hoots WK, Wada H, Levi M. Toward definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001; 86:1327-1330.
11. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity classification system. Crit Care Med 1985; 13:818-829.
12. Aksu S, Beyazit Y, Haznedaroglu IC, Goker E, Kekilli M, Karakaya J, et al. Unchanged global fibrinolytic capacity during the course of hematopoietic stem cell transplantation. Blood Coagul Fibrinolysis 2006; 17:47-51.
13. Kidokoro A, Iba T, Fukunaga M, Yagi Y. Alterations in coagulation and fibrinolysis during sepsis. Shock 1996; 5:223-228.
14. Kinasewitz GT, Yan SB, Basson B, Comp P, Russell JA, Cariou A, et al. Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism. Crit Care 2004; 8:82-90.
15. Seljeflot I, Eritsland J, Andersen P, Arnesen H. Global fibbrinolytic capacity assessed by the serum D-dimer test. Correlation between basal and stimulated values. Thromb Res 1994; 75:157-162.
16. Seljeflot I, Arnesen H, Eritsland J, Smith P. D-dimer test after standardized coagulation. Fibrinolysis 1993; 7:303-307.
17. Prisco D, Paniccia R, Bandinelli B, Filippini M, Brunelli T, Zarone N, et al. Euglobulin lysis time in fresh and stored samples. Am J Clin Pathol 1994; 102:794-796.
18. Dogan A, Tunc B, Ergene O, Ozaydin M, Nazli C, Altinbas A, Gedikli O. Evaluation of overall fibrinolytic activity in patients with coronary artery ectasia: global fibrinolytic capacity. Int J Cardiovasc Imaging 2003; 19:465-471.
19. Guldiken S, Demir M, Turgut B, Altun BU, Arikan E, Kara M. Global fibrinolytic capacity in patients with subclinical hypothyroidism. Endocr J 2005; 52:363-367.
20. Yildiz BO, Haznedaroglu IC, Kirazli S, Bayraktar M. Global fibrinolytic capacity is decreased in polycystic ovary syndrome, suggesting a prothrombotic state. J Clin Endocrinol Metab 2002; 87:3871-3875.
21. Van der Poll T, Levi M, Nick JA, Abraham E. Activated protein Cinhibits local coagulation after intrapulmonary delivery of endotoxin in humans. Am J Respir Crit Care Med 2005; 171:1125-1128.
22. Nilsson G, Astermark J, Lethagen S, Vernersson E, Berntorp E. Protein C levels can be forcasted by global haemostatic tests in critically ill patients and predict long-term survival. Thromb Res 2005; 116:15-24.
23. Wiedermann CJ. Improvement in coagulation markers with antithrombin - beneficial in severe sepsis? Crit Care Med 2004; 32:1968-1969.
24. Dhainaut JF, Shorr AF, Macias WL, Kollef MJ, Levi M, Reinhart K, Nelson DR. Dynamic evolution of coagulopathy in the first day of severe sepsis: relationship with mortality and organ failure. Crit Care Med 2005; 33:341-348.
25. Fourrier F, Chopin C, Goudemand J, Hendrycx S, Caron C, Rime A, et al. Septic shock, multiple organ failure, and disseminated intravascular coagulation: compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 1992; 101:816-823.